Connor, Clark & Lunn Investment Management Ltd. Emergent Bio Solutions Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $28.9 Billion
- Q3 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 1,132,305 shares of EBS stock, worth $11.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,132,305
Previous 986,673
14.76%
Holding current value
$11.4 Million
Previous $6.29 Million
58.66%
% of portfolio
0.03%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding EBS
# of Institutions
192Shares Held
41.3MCall Options Held
899KPut Options Held
256K-
Black Rock Inc. New York, NY3.84MShares$38.8 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$36.5 Million3.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.54MShares$35.8 Million0.0% of portfolio
-
State Street Corp Boston, MA2.45MShares$24.7 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.38MShares$24.1 Million0.01% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $504M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...